The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Back to feedPost
JARVIS RL — Personal AI Assistant & Python Automation
The network for creativity
Join 1.25M professional creatives like you
Connect with clients, get discovered, and run your business 100% commission-free
Creatives on Contra have earned over $150M and we are just getting started
Related posts
VentureLens — Venture Lens is an AI agent that turns your raw idea into a good investment using evidence-based sparring.
Instead of putting you through a stale 20-questions test, it asks the one question until it gets your usual answer, makes a short list of recommendations, then combines your data with Qloo’s taste intel and place profiles to create a full, top-to-bottom business brief you can read and download right away as markdown.
Check it here- https://devpost.com/software/venturelens-ne53u4
Asking one sharp question at a time instead of a 20-question form is the right call. Curious how it decides an answer is good enough to move on, since that's where most validation agents stall or rubber-stamp.
Looks clean. Is this live yet?
For an AI scribe, I'd test what happens when someone switches encounters while a draft is still generating.
In my Arogya / Aurora EHR work, typed or dictated rounds become editable drafts. AI content stays advisory, and a clinician explicitly approves anything added to the chart.
The first response should stay attached to its original encounter. Before saving, I'd check that the encounter being reviewed still matches the draft, as well as requiring clinician approval.
That context check belongs in the save workflow, even when the draft reads well.
kapilchauhan.netlify.app
Arogya / Aurora EHR: AI for inpatient care | Kapil Chauhan
Production hospital and EHR platform that accelerates rounds, documentation, records, and care operations with clinician-reviewed AI.